SULT1D1P

Across TCGA pan-cancer cohorts, SULT1D1P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated SULT1D1P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher SULT1D1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SULT1D1P expression acts as an unfavorable survival marker, although some lineages such as BLCA and CESC show a favorable association.

MESO, KIRP, and KIRC are the cancer types where SULT1D1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.337	0.616	<.001	177	view →
KIRP	DFS	Tertile	All	0.168	0.610	<.001	108	view →
KIRC	DFS	Tertile	IV	0.216	0.534	<.001	96	view →
OV	DFS	Tertile	All	0.305	0.549	<.001	78	view →
BRCA	DFS	Tertile	All	0.777	0.908	<.001	48	view →
BLCA	OS	Quartile	II,III,IV	0.585	0.350	.008	40	view →
KICH	OS	Tertile	All	0.155	0.926	<.001	36	view →
TGCT	DFS	Tertile	III,IV	0.505	1.000	.016	24	view →
READ	DFS	Tertile	IV	0.300	0.692	.004	18	view →
ESCA	DFS	Tertile	II,III,IV	0.171	1.000	.008	18	view →
LUSC	OS	Tertile	III,IV	0.054	0.768	<.001	18	view →
PRAD	OS	Tertile	All	0.632	0.884	.005	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

SULT1D1P–MESO (OS)

Open the MESO breakdown →